,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Joshua R. Disbrow', 'age': 47, 'title': 'CEO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 567308, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
1,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Mark K. Oki CPA', 'age': 53, 'title': 'CFO, Sec. & Treasurer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 217596, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
2,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Christopher  Brooke', 'title': 'Chief Operating Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
3,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Ms. Victoria  Cordova', 'title': 'VP of People & Culture', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
4,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Jarrett T. Disbrow Ph.D.', 'age': 47, 'title': 'Chief Bus. Officer & Pres of Consumer Health', 'yearBorn': 1975, 'fiscalYear': 2019, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
5,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Greg  Pyszczymuka', 'title': 'Chief Commercial Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
6,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Russ  McMahen', 'title': 'Sr. VP of R&D', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
7,373 Inverness Parkway,Suite 206,Englewood,CO,80112,United States,855-298-8246,https://aytubio.com,Drug Manufacturers—Specialty & Generic,Drug Manufacturers—Specialty & Generic,Healthcare,Healthcare,"Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",164,"{'maxAge': 1, 'name': 'Mr. Ryan J. Selhorn CPA', 'age': 40, 'title': 'Exec. VP of Fin. & Bus. Optimization', 'yearBorn': 1982, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,1.57,1.59,1.52,1.69,1.57,1.59,1.52,1.69,0.0,-0.365836,-1.528302,30907,30907,33900,18080,18080,1.57,1.62,3000,3000,8948005,1.38,4.8,0.085943475,1.732,2.4492,0.0,0.0,USD,12038890,-0.30809,2564473,5523460,352772,320167,1690761600,1693440000,0.0639,0.049089998,0.47617,11.85,0.065799996,5523460,10.825,0.14965358,1656547200,1688083200,1680220800,-32077000,-12.26,-1.06,1:20,1672963200,0.116,-0.911,-0.595,0.14113986,NCM,EQUITY,AYTU,AYTU,"Aytu BioPharma, Inc.","Aytu BioPharma, Inc.",1222349400,America/New_York,EDT,887c97be-184b-3c68-ac18-63df37b78e4c,finmb_291629081,-14400000,1.62,5.0,5.0,5.0,5.0,2.0,buy,1,19179000,5.074,-13218000,25094000,0.623,0.919,104115000,61.337,37.535,-0.087969996,-0.62861,52283000,-11423500,-21589000,-0.061,0.60423,-0.12695,-0.21363,USD,
